What environmental exposures are associated with the development or worsening of thyroid disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Environmental Exposures That Cause Thyroid Disease

The most clinically significant environmental exposures that cause thyroid disease are ionizing radiation, excess iodine (from medications, contrast agents, and topical disinfectants), certain medications (amiodarone, interferon-α, interleukin-2), and emerging evidence strongly implicates air pollution (particularly PM2.5 and PM10), heavy metals, and endocrine-disrupting chemicals.

Established Environmental Causes

Ionizing Radiation

Exposure to ionizing radiation is the only firmly established environmental risk factor for thyroid carcinoma, particularly papillary thyroid cancer 1. The risk is greatest in younger individuals at the time of exposure. Following the Chernobyl nuclear reactor explosion in 1986, thyroid cancer incidence in Ukrainian children increased 80-fold from baseline rates of 0.5-1.0 per million children 1. High doses of radioactive iodine (I-131) above 20 mGy are associated with hypothyroidism and increased thyroid antibody formation, potentially leading to autoimmune thyroid disease 2.

Key clinical point: Patients with a history of childhood radiation exposure to the head, neck, or chest require lifelong thyroid surveillance.

Excess Iodine Exposure

Iodine-induced thyroid dysfunction can manifest as either hyperthyroidism or hypothyroidism, depending on baseline thyroid status and iodine sufficiency 3, 4.

Sources of excess iodine include:

  • Iodinated contrast agents used in radiologic studies 4
  • Amiodarone (contains 37% iodine by weight) - causes thyrotoxicosis in up to 6% of patients 3
  • Topical povidone-iodine disinfectants with prolonged exposure 4
  • Kelp, seaweed soup, and iodine supplements 3
  • Lugol's solution and potassium iodide 4

Iodine-induced hyperthyroidism (Jod-Basedow phenomenon) typically occurs in patients with underlying thyroid autonomy, especially those from iodine-deficient areas, and is usually self-limited, lasting 1-18 months 3. Conversely, chronic excess iodine in iodine-sufficient individuals induces autoimmune thyroiditis, elevated TSH, lower thyroid hormone levels, and hypothyroidism 4.

Clinical algorithm for iodine exposure:

  1. Obtain detailed medication history including over-the-counter supplements
  2. Ask about recent imaging studies with contrast
  3. Check urinary iodine concentration if exposure suspected but unclear from history
  4. Monitor thyroid function at 1 and 3 months after known iodine exposure, then every 3-6 months 3

Medications

Amiodarone: Monitor thyroid function before initiation, at 1 and 3 months after starting, then every 3-6 months thereafter 3. Amiodarone-induced thyrotoxicosis occurs through multiple mechanisms including iodine-induced hyperthyroidism, destructive thyroiditis, and induction of thyroid autoimmunity.

Interferon-α and Interleukin-2: These immunomodulatory drugs increase risk for thyrotoxicosis, especially in patients with pre-existing thyroid autoimmunity 3. A meta-analysis found that 46% of patients with positive thyroid peroxidase antibodies developed thyroid dysfunction after interferon-α therapy for hepatitis C, compared to only 5% with negative antibodies 3. Thyrotoxicosis can result from either painless thyroiditis (most common) or Graves' disease.

Emerging Environmental Threats

Air Pollution

Recent high-quality evidence demonstrates that particulate matter exposure significantly impacts thyroid function. A 2026 cross-sectional study of 73,900 Chinese adults found that long-term PM10 exposure was associated with higher odds of overt hypothyroidism (OR 1.36 for highest vs. lowest quartile), subclinical hypothyroidism (OR 1.14), autoimmune thyroiditis (OR 1.10), and thyroglobulin antibody positivity (OR 1.24) 5. Each 10 µg/m³ increase in PM10 concentration increased odds of overt hypothyroidism by 16% 5.

A 2023 meta-analysis of 357,226 participants found significant associations between PM2.5, PM10, NO2, SO2, and CO exposure and decreased free thyroxine (FT4) levels, with percent changes ranging from -0.593% to -3.925% 6. PM2.5 exposure was also associated with hypothyroxinemia and elevated TSH 6. Critically, PM2.5 exposure during the first trimester of pregnancy was associated with lower FT4 levels in pregnant women 6.

A 2026 mechanistic review identified that PM2.5 causes thyroid damage through oxidative stress, inflammatory response, hypothalamic-pituitary-thyroid axis dysfunction, direct disruption of thyroid follicular structure, and intestinal-thyroid axis dysregulation 7.

Heavy Metals and Endocrine-Disrupting Chemicals

A 2026 analysis of 1847 US adults found that mixed environmental chemical exposure (including per- and polyfluoroalkyl substances, heavy metals, and phthalate metabolites) showed a positive association with thyroid disease risk (crude OR = 2.74) 8. Five chemicals accounted for 68% of the mixture effect: 2-(N-methyl-PFOSA) acetate (28%), perfluorohexanesulfonic acid (14%), blood cadmium (10%), blood lead (8%), and mono(2-ethyl-5-oxo) phthalate (8%) 8.

Age is a critical modifier: Individuals over 63 years showed 80% higher predicted thyroid disease risk at high exposure levels compared to younger adults 8.

Phthalates and bisphenol A (BPA) cause hyperthyroidism and subclinical hyperthyroidism by stimulating the thyroid gland to produce excess triiodothyronine and thyroxine 9. These endocrine-disrupting chemicals are ubiquitous in consumer products including personal care products, food contact materials, and medical equipment 10.

A 2026 comprehensive review confirmed that heavy metals and endocrine-disrupting chemicals contribute to both thyroid dysfunction and carcinogenesis, though the clinical relevance varies across different compound classes 11.

Clinical Implications

High-risk populations requiring enhanced surveillance:

  • Individuals with childhood radiation exposure to head/neck
  • Patients taking amiodarone, interferon-α, or interleukin-2
  • Those living in areas with high air pollution (PM2.5 >35 µg/m³, PM10 >130 µg/m³)
  • Pregnant women in first trimester in polluted areas
  • Adults over 63 years with occupational or residential exposure to heavy metals or endocrine-disrupting chemicals
  • Patients with recent iodinated contrast exposure or chronic topical iodine use

Practical screening approach:

  1. Obtain environmental exposure history including occupation, residence location, and air quality
  2. Screen thyroid function (TSH, free T4) before and after known exposures
  3. Consider thyroid antibody testing in high-risk individuals
  4. For pregnant women in polluted areas, check thyroid function in first trimester
  5. Counsel smoking cessation, as smoking increases risk and severity of thyroid eye disease 12

The evidence base for air pollution and chemical mixtures is rapidly evolving, with the most recent 2026 studies providing the strongest evidence to date for these associations. While ionizing radiation and excess iodine remain the most established causes, clinicians must now consider environmental pollution as a modifiable risk factor for thyroid disease.

References

Guideline

screening for thyroid disease: recommendation statement.

American family physician, 2004

Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Guideline

espen micronutrient guideline.

Clinical Nutrition, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.